Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
Patients with inflammatory bowel disease (IBD) are at an increased risk of developing intestinal neoplasia—particularly colorectal neoplasia, including dysplasia and colorectal cancer (CRC)—as a primary consequence of chronic inflammation. While the current incidence of CRC in IBD is lower compared...
Main Authors: | Jordan E. Axelrad, Shailja C. Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-05-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756284820920779 |
Similar Items
-
The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review
by: Jordan E. Axelrad, et al.
Published: (2021-03-01) -
Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists
by: Xian-rui Wu, et al.
Published: (2018-01-01) -
Sex-based differences in inflammatory bowel diseases: a review
by: Sheila D. Rustgi, et al.
Published: (2020-04-01) -
Modern Endoscopic Imaging in Diagnosis and Surveillance of Inflammatory Bowel Disease Patients
by: Gheorghe Hundorfean, et al.
Published: (2018-01-01) -
Modern therapy for inflammatory bowel disease
by: Novaković Aleksandra
Published: (2017-01-01)